Prevention of stroke in patients with chronic coronary syndromes or peripheral arterial disease

Keyphrases

• Peripheral Arterial Disease 100%
• Chronic Coronary Syndrome 100%
• Stroke Prevention 100%
• Stroke Risk 42%
• Anticoagulation 28%
• Antithrombotic Therapy 28%
• Dual Antiplatelet Therapy 28%
• Bleeding Risk 14%
• Ultra-low Dose 14%
• Atherothrombosis 14%
• Chronic Treatment 14%
• Antiplatelet Therapy 14%
• Glycemic Control 14%
• Non-pharmacological Methods 14%
• Atrial Fibrillation 14%
• Prior Myocardial Infarction 14%
• Lifestyle Characteristics 14%
• Major Adverse Cardiovascular Events 14%
• Hemorrhagic Stroke 14%
• Pathophysiological Mechanisms 14%
• Risk Factor Profile 14%
• Aspirin 14%
• Thromboembolism 14%
• Low-density Lipoprotein 14%
• Control Characteristics 14%
• Net Clinical Benefit 14%
• Blood Pressure 14%
• Dual Antithrombotic Therapy 14%
• Ischemic Stroke 14%
• Lipoprotein Levels 14%

Medicine and Dentistry

• Apoplexy 100%
• Heart Muscle Ischemia 100%
• Arteriosclerosis Obliterans 100%
• Antithrombotic Therapy 42%
• Antiplatelet 42%
• Anticoagulation 28%
• Bleeding 28%
• Low Drug Dose 14%
• Acetylsalicylic Acid 14%
• Thromboembolism 14%
• Thrombosis 14%
• Cerebral Hemorrhage 14%
• Atrial Fibrillation 14%
• Cardiovascular Disease 14%
• Blood Pressure 14%
• Low-Density Lipoprotein 14%
• Brain Ischemia 14%
• Glycemic Control 14%
• Myocardial Infarction 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Peripheral Occlusive Artery Disease 100%
• Heart Muscle Ischemia 100%
• Cerebrovascular Accident 100%
• Antiplatelet 42%
• Antithrombotic Therapy 42%
• Bleeding 28%
• Heart Infarction 14%
• Acetylsalicylic Acid 14%
• Thrombosis 14%
• Atrial Fibrillation 14%
• Thromboembolism 14%
• Low Density Lipoprotein 14%
• Brain Hemorrhage 14%
• Cardiovascular Disease 14%
• Brain Ischemia 14%